Edwards Lifesciences (EW) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 36.1% | 36.4% | 30.6% | 31.7% | 23.6% | 22.8% | ||
| Changes by years, y/y, % | +12pp | +0pp | -6pp | +1pp | -8pp | -0.8% | |||
Edwards Lifesciences. EBITDA margin, %
Edwards Lifesciences. EBITDA margin, changes, pp
Edwards Lifesciences (EW) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 33.3% | 26.1% | 25.0% | 8.48% | 27.8% | 22.8% | |
| Changes by years, y/y, % | +2pp | -5pp | -7pp | -26pp | -5pp | |||
| Changes by quarters, q/q, % | -2pp | -7pp | -1pp | -16pp | +19pp | |||